Navigation Links
Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Date:10/20/2011

>

8.3.7 Annual Cost of Therapy 47

8.3.8 Primary Research 47

8.3.9 Expert Panels 47

8.4 Contact Us 48

8.5 Disclaimer 48

8.6 Sources 48

1.1 List of Tables

Table 1: Breast Cancer, Incidences and Mortality, By Country, 2008-2030 5

Table 2: Breast Cancer, Global, Market Size Forecasts ($bn), 2010–2020 8

Table 3: Five-Year Relative Survival Rates, By Stages 14

Table 4: Approval Status of Afinitor 30

Table 5: Drug Risk Benefit Score of Afinitor 31

Table 6: Annual Cost of Therapy of Afinitor 34

Table 7: Afinitor, Breast Cancer, Global, Sales Forecasts ($m), 2013–2020 35

Table 8: Afinitor, Breast Cancer, the US, Sales Forecasts ($m), 2013–2020 36

Table 9: Afinitor, Breast Cancer, the UK, Sales Forecasts ($m), 2013–2020 37

Table 10: Afinitor, Breast Cancer, France, Sales Forecasts ($m), 2013–2020 38

Table 11: Afinitor, Breast Cancer, Germany, Sales Forecasts ($m), 2013–2020 39

Table 12: Afinitor, Breast Cancer, Italy, Sales Forecasts ($m), 2013–2020 40

Table 13: Afinitor, Breast Cancer, Spain, Sales Forecasts ($m), 2013–2020 41

Table 14: Afinitor, Breast Cancer, Japan, Sales Forecasts ($m), 2013–2020 42

1.2 List of Figures

Figure 1: Distribution by Incidence and Mortality, Most Commonly Diagnosed Cancers, Worldwide, 2010 6

Figure 2: Breast Cancer, Global, Market Size Forecasts ($bn), 2010–2020 8

Figure 3: Top 10 Most Frequent Cancers on Incidence-Mortality Matrix, Worldwide, 2010 9

Figure 4: Incidence per 100,000, Breast Cancer, Selected Countries, 1975-2005 10

Figure 5: Incidence per 100,000, Breast Cancer, Selected Countries, 1975-2005 10

Figure 6: Breast Cancer, Incidence, Worldwide, 2008-2030 11

Figure 7: All Cancers, Incidence, Worldwide, 2008-2030 11

Figure 8: Mortality per 100,000, Breast Cance
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
4. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. FDA Approves New Indication for Afinitor
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
11. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China , ... of Directors declared a special cash dividend of US$0.30 ... ("ADS")) on the Company,s outstanding ordinary shares. The total ...
(Date:7/28/2014)... 28, 2014   Cardioxyl Pharmaceuticals, Inc. announced ... that CXL-1427, a novel potential treatment for acute decompensated ... The company has now initiated dosing of hospitalized patients ... trial designed to further evaluate the drug,s safety and ... The Phase I clinical trial evaluated the safety and ...
(Date:7/28/2014)... 28, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2014 Financial Results and Highlights Conference CallWhen:Monday, August 4 ... How:Live on the Internet. Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... Technologies Inc., the leading developer of non-invasive electrocardiographic ... $7.5 million Series "C" financing.  The proceeds from ... commercial efforts related to its ECVUE ™ ... (Logo: http://photos.prnewswire.com/prnh/20110531/DC10432LOGO ) CardioInsight recently ...
...  MAKScientific, LLC, a privately held company focused on the ... that it has entered into an exclusive, worldwide option ... BIIB ) to develop and commercialize drug candidates for ... diseases. Under the agreement, Biogen Idec will ...
Cached Medicine Technology:CardioInsight Announces Closing of $7.5 Million Equity Financing 2
(Date:7/28/2014)... to accept the diagnosis "growing pains" when they complained ... involving 3,000 adolescents has now shown that the knee ... the study that one in three young people between ... pain in their knees. Seven percent of the adolescents ... knee," says physiotherapist and PhD Michael Skovdal Rathleff from ...
(Date:7/28/2014)... WASHINGTON, July 28, 2014A group of researchers in Taiwan ... able to detect an early complication of diabetes sooner, ... proves safe and effective in clinical trials, it may ... effective treatment of this complication, called diabetic autonomic neuropathy, ... and Type 2 diabetes. The condition progressively affects the ...
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... Northridge, CA (PRWEB) July 28, 2014 ... a $100 coupon for new patients. Finding a new dentist ... anxiety or dental issues that have gone untreated and worry ... provider. Dr. Ariz specializes in patients with special concerns and ... patients feels comfortable and right at home. This special coupon ...
(Date:7/28/2014)... Australia (PRWEB) July 28, 2014 What ... a happier lifestyle can often be a struggle that ... channel, psychic and medium, Lynette Leckie-Clark provides simple how-to ... book “The Magic of You.” With inspiring spiritual affirmations ... you can find empowerment, confidence and motivation for everyday ...
Breaking Medicine News(10 mins):Health News:Many people never grow out of their growing pains 2Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Gender inequalities in health: A matter of policies 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2
... up to Take Control of Health, Take off Pounds to ... Gain ... a year makes!,What a difference people can make when they join together ... Washington,D.C. to join Dr. Ian Smith, Patti LaBelle, Yolanda Adams, Michael Strahan,Steve ...
... a,Washington, D.C.-based research, evaluation and consulting organization,today released ... finds,low awareness and knowledge levels about HIV/AIDS, but ... important predictors for heightened,awareness., Some key findings ... -- Only 1 percent of respondents were ...
... April 2, 2008 The Richard B. and,Lynne V. ... the Institute,s Board of Directors. As a director, she ... "We are delighted to have Mary Cheney join ... of the Cheney family,actively involved in shaping the major ...
... Oaks,Development Group announced today the company has closed on ... behind St. David Medical Center in Austin,Texas. A 29,724-square-foot ... being converted to Oaks, unique tenant-ownership model., Oaks, ... limited liability,company (L.L.C.). Tenant partners split ownership interest of ...
... Sky,One Medical, Inc. (OTC Bulletin Board: CSKI) ("China Sky ... pharmaceutical,medicinal and diagnostic products in China, today announced record,financial ... December 31,2007., Fourth Quarter 2007 Highlights ... from the fourth quarter of ...
... stalled at just 9 percent, HARTFORD, Conn., April ... need to re-examine its value proposition to break,out of ... broader market,according to a new study by Conning Research ... sold primarily by specialist agents,to a niche market of ...
Cached Medicine News:Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 2Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 3Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 4Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 2Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 3Health News:Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors 2Health News:Oaks Development Group Acquires Medical Office Building in Austin, Texas 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 3Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 4Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 5Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 6Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 7Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 8Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 9Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 10Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 11Health News:Conning Research: Long Term Care Insurance Industry Continues to Search for Broader Market 2
... 300 watt xenon Light ... Endoscopy shares your commitment to ... highest quality care available through ... of advanced surgical instruments and ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
The new X7000 light source is specifically tuned for the demanding requirements of Progressive Scan High Definition. The X7000 Lightsource uses a 300 Watt Xenon Elliptical Bulb for crystal clear illu...
... STORZ has brought arthroscopic shaver systems to ... the introduction of the Powershaver SL. Just ... the market leader in surgical endoscopy, the ... important and highly specialized field of arthroscopic ...
Medicine Products: